Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.78 EUR | +2.09% | +6.70% | +13.18% |
04-26 | Transcript : Terveystalo Oyj, Q1 2024 Earnings Call, Apr 26, 2024 | |
04-26 | Terveystalo Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analyst opinion has improved significantly over the past four months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company is in debt and has limited leeway for investment
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.18% | 1.17B | B- | ||
-17.07% | 16.85B | B+ | ||
+3.60% | 12.34B | B | ||
+5.64% | 11.77B | B+ | ||
+4.26% | 10.28B | B+ | ||
+25.36% | 8.38B | B | ||
-0.68% | 7.88B | A- | ||
+22.18% | 7.29B | D | ||
+5.77% | 6.75B | B- | ||
+52.00% | 4.69B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- TTALO Stock
- Ratings Terveystalo Oyj